Nivolumab trials for Clinical Stage IV Cutaneous Melanoma AJCC v8
All Nivolumab trials · All Clinical Stage IV Cutaneous Melanoma AJCC v8 trials
7
Recruiting trials
Phase breakdown
Phase 1 3Phase 2 5
Recruiting trials studying Nivolumab for Clinical Stage IV Cutaneous Melanoma AJCC v8
- A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
Common questions
How many trials study Nivolumab for Clinical Stage IV Cutaneous Melanoma AJCC v8?
7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.